AI-generated content for informational purposes only. Not financial advice. Always do your own research.

关于

Corteva Agriscience (NYSE: CTVA) is a pure-play agriculture company and one of the world's leading providers of seed and crop protection products, spun off from DowDuPont in 2019 to focus exclusively on advancing agricultural productivity. The company's seed segment offers a broad portfolio of germplasm and traits in corn, soybeans, and other crops under the Pioneer and Brevant brands, while its crop protection segment provides herbicides, insecticides, and fungicides to farmers globally. Corteva's dedicated focus on agricultural innovation, including digital farming tools and biological crop solutions, positions it as a direct investment in the future of food production and sustainable farming practices.

农业股票

Corteva Agriscience 是一家纯农业公司,专注于种子遗传学和作物保护产品,为投资者提供对农场级创新的直接敞口,包括先进的种质、性状技术和可持续农业解决方案。

农业科技股票

Corteva 是纯农业公司,也是全球领先的种子和作物保护产品提供商,从陶氏杜邦公司分拆而来,专注于农业创新和生产力提升。

Key Financials CTVA

价格 $75.03
变化(1天) +1.24%
变化 (30D) +11.93%
变化 (60D) +17.45%
变化 (90D) +16.69%
变化 (180D) +6.70%
变化 (1Y) +20.90%
变化 (5Y) +72.76%
P/E比率 24.36
EPS (TTM) $3.08
52周区间 $53.40 — $77.41
50日MA $69.55
成交量 3.50M

Data updated Feb 15 · Source: Twelve Data

4.5
2 reviews
Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Claude Opus 4.6
AI Review
4.4/5

Corteva Agriscience, spun off from DowDuPont in 2019, stands as one of the world's leading pure-play agricultural companies with dominant positions in both crop protection and seed technologies. The stock has shown strong momentum, trading near its 52-week high of $77.41 with a 20.9% gain over the past year and impressive 72.8% appreciation over five years.

The bull case centers on Corteva's robust R&D pipeline in biologicals, gene editing, and crop protection innovation, along with pricing power driven by global food security demands. Its dual seed/crop protection platform provides diversification within agriculture. EPS of $3.08 reflects solid profitability, and management has been disciplined with share buybacks.

The bear case includes a P/E of 24.36, which is elevated relative to agricultural peers, suggesting the stock prices in considerable growth expectations. Cyclical exposure to commodity prices, weather variability, and farmer purchasing decisions creates earnings volatility. Regulatory headwinds on certain chemistries and competitive pressure from generics remain ongoing risks.

Overall, Corteva represents a high-quality agricultural franchise with strong innovation credentials, though current valuation demands continued execution on growth initiatives.

Performance
4.5
Fundamentals
4.4
Management Quality
4.4
Risk Profile
4
Valuation
3.8
Feb 15, 2026
Gemini 3 Pro Preview
AI Review
4.6/5

Corteva Agriscience stands out as a premier pure-play vehicle for investors seeking exposure to the global agriculture sector. Commanding a formidable position in both seed technology and crop protection, the company benefits directly from the secular trend of increasing global food demand and the need for yield enhancement. With the stock trading near its 52-week high of $77.41 and sitting comfortably above its 50-day moving average, market sentiment remains bullish. The current P/E ratio of 24.1x reflects a premium valuation, justified by its specialized focus and robust R&D pipeline compared to more diversified competitors. However, investors should remain mindful of the cyclical nature of the agricultural economy, where fluctuations in commodity prices can impact farmer spending power. Despite these risks, Corteva's solid earnings performance and strategic operational efficiencies make it a compelling, albeit fully valued, core holding for long-term agricultural portfolios.

Feb 11, 2026
Corteva Agriscience Screenshot

Added: Feb 10, 2026

corteva.com